PPA
AMGN icon

Pacific Point Advisors’s Amgen AMGN Stock Holding History

Pacific Point Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,431
Closed -$1.53M – 133
2025
Q3 		$1.53M Buy
5,431
+90
+2% +$26.1K 0.89% 32
2025
Q2 		$1.49M Buy
5,341
+140
+3% +$39.7K 0.81% 35
2025
Q1 		$1.62M Buy
5,201
+374
+8% +$110K 0.9% 18
2024
Q4 		$1.39M Buy
+4,827
New +$1.43M 0.85% 22

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Pacific Point Advisors's AMGN Position: Q4 2025 in Review

Pacific Point Advisors sold out of Amgen (AMGN) in Q4 2025, closing a stake of 5,431 shares — an estimated $1.53M sold.

Pacific Point Advisors first reported a position in AMGN in Q4 2024 and held it in 4 quarters. The position peaked at $1.62M in Q1 2025. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Pacific Point Advisors reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Pacific Point Advisors sold 5,431 Amgen shares in Q4 2025, an estimated $1.53M.
  • Pacific Point Advisors first reported a position in Amgen in Q4 2024 and held it in 4 quarters.
  • Pacific Point Advisors's Amgen position peaked at $1.62M in Q1 2025.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Pacific Point Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.